India’s Dr. Reddy’s Laboratories said it has agreed to buy eight drugs from Israel’s Teva Pharmaceutical Industries Ltd. for $350 million, as the Indian drugmaker seeks to gain a foothold in the U.S. market by selling more sophisticated treatments.
from WSJ.com: US Business http://ift.tt/1PlPSJs
via IFTTT
No comments:
Post a Comment